Medical Futures Inc. Company Overview
Medical Futures Inc. is a niche pharmaceutical company that sells both pharmaceutical and natural therapeutic products into the North American marketplace. Founded in 2000, Medical Futures is privately owned and based in Richmond Hill, Ontario. The staff are dedicated to advancing healthcare for both Canadians and Americans. Medical Futures actively seeks out and researches new products for introduction into several therapeutic areas including:
- Gastroenterology
- Pain Management
- Respirology
- Dermatology
- Women’s and Men’s Health.
To date, Medical Futures Inc. has introduced several highly successful products in both the prescription and natural health markets. Our current focus is in natural health products with the introduction of Florastor in 2004. It is currently the world’s leading probiotic, available in over 80 countries with over 10 billion doses dispensed. Our next natural health product was launched in 2006 named Iberogast. Iberogast is a herbal combination prokinetic product to treat functional dyspepsia and inflammatory bowel disease. Proferrin launched in 2007, a unique heme-based iron product with few side-effects, rounds out our current offering.
Medical Futures Inc. has also licensed drugs such as Moviprep, Pegalax, Cortifoam, Purinethol, and Sanvar.
To get a glimpse of the past and insight towards the future of Medical Futures Inc please click on the News section.
We continue to invest in your health.
Mission
With a mission to bring innovative products from around the world to the North American market, Medical Futures Inc. aims to provide new, more effective treatment options in areas of unmet patient need.
Vision
Driven to become the leading source of safe, effective and affordable health products in North America, we are committed to improving the overall quality of life of the patients who use our products.
